Retatrutide
10mg · Sample tested 2026-10-22
99.89%
Reported sample purity
- Report reference
- RT10-2026102175001
- Measured sample net content
- 12.18mg
99.89% · reported 10mg sampleInvestigational triple-receptor agonist studied across GIP, GLP-1, and glucagon pathways.
Retatrutide is an investigational triple-receptor agonist being studied for its activity across the GIP, GLP-1, and glucagon receptor pathways. It has gained significant attention in metabolic research because of its multi-pathway mechanism and its role in studies related to body-weight regulation, energy balance, appetite signaling, and metabolic function.
Retatrutide is commonly discussed in research settings because it targets three incretin-related pathways instead of only one or two. This makes it a high-interest compound in obesity, metabolic health, glucose regulation, and energy-expenditure research.
Retatrutide is being studied as a triple agonist of the GIP, GLP-1, and glucagon receptors. Research interest centers on incretin pathway signaling, appetite and satiety pathway modulation, and energy expenditure regulation.
Active research area — see references below.
Active research area — see references below.
Active research area — see references below.
Active research area — see references below.
Active research area — see references below.
Active research area — see references below.
| Sequence | Synthetic 39-aa triple agonist (proprietary) |
|---|---|
| Molecular Weight | ~4731 g/mol |
| Purity | 99.89% LCMS/HPLC · RT10-2026102175001 (10mg sample only) |
| Storage | Lyophilized: -20°C. Reconstituted: 2–8°C. Store separately. |
| Reconstitution | Bacteriostatic water; 3mL BAC per 10mg vial (3.33 mg/mL). |
| Half-life | Extended (under research) |
Research-use reconstitution reference for Retatrutide. For qualified research settings only. Not medical advice — consult a qualified professional and follow applicable lab, safety, and regulatory protocols.
Retatrutide should be reconstituted and stored separately to reduce cross-contamination risk.
This calculator is for research-use concentration math only. It is not dosage guidance, medical advice, treatment instruction, or human-use recommendation. Assumes a standard 100-unit insulin syringe (1 mL = 100 units). Always follow applicable lab, safety, and regulatory protocols.
10mg · Sample tested 2026-10-22
99.89%
Reported sample purity
Owner-supplied analytical reports for the identified samples, not a guarantee for every vial or strength. The documents state that the issuer and partner laboratory do not hold CMA/CNAS accreditation and the reports have no legal certification validity. They do not establish regulatory approval. Reported net content is a sample measurement, not the labeled strength. These reports are not Janoshik certificates.
Feedback about shopping with Protides Biotech. These comments are not reviews of Retatrutide or its effects.
“Can we talk about the customer service? Because honestly 10/10. I had so many questions before placing my order and they answered everything without making me feel like I was bothering them. Delivery was quick too. Definitely appreciate the professionalism.”
“I was nervous about ordering at first but the Protide team was really patient with me. They answered my questions and explained the ordering process. Everything came properly packaged and the communication was excellent. Will definitely recommend their customer service.”
Request custom vial strengths, larger quantities, or sourcing for compounds not currently in our catalog. Our team will review and respond with availability and pricing.
Start Special OrderDisclaimer: Product information is provided for research and educational purposes only. This website does not provide medical advice, diagnosis, treatment, dosage instructions, or human-use recommendations.